Miller R T, Shah R S, Cattley R C, Popp J A
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709, USA.
Toxicol Appl Pharmacol. 1996 Jun;138(2):317-23. doi: 10.1006/taap.1996.0130.
WY-14,643 (WY) and methylclofenapate (MCP) are peroxisome proliferators (PP) and hepatocarcinogens in rats. MCP causes hepatic polyploidization and preferentially induces replicative DNA synthesis in binucleate tetraploid hepatocytes (2 X 2N) in young Alpk:AP rats. To compare the effect of WY and MCP on hepatocyte ploidy and ploidy-specific DNA synthesis, male F344 rats were fed WY (0.1% in diet) or gavaged with MCP (25 mg/kg/day in corn oil) for 2, 5, or 10 days. Four rats per treatment group (including corn oil and diet control groups) were euthanized and the livers perfused at each time point. To identify cells undergoing DNA synthesis, all animals received BrdU by continuous infusion for 2 or 5 days prior to euthanasia. Hepatocyte ploidy and DNA synthesis were determined using one- or two-parameter flow cytometry. Averages +/- SEM for adult male F344 rats as a percentage of total hepatocytes for each ploidy subclass are 2N = 3.4 +/- 0.7%, 4N = 69.9 +/- 1.9%, 2 X 2N = 14.4 +/- 2.4%, 8N = 2.2 +/- 0.4%, and 2 X 4N = 9.6 +/- 0.9%. Significant alterations were not induced in the proportions of 2 X 2N or 4N ploidy subclasses by WY or MCP at any time point. However, WY caused increases in 8N hepatocytes at 2, 5, and 10 days (2 days, 5.2% vs 2.2% for controls; 5 days, 7.0% vs 3.1% for controls; 10 days, 6.4% vs 3.6% for controls) as did MCP at 5 and 10 days (5 days, 6.3% vs 2.5% for controls; 10 days, 5.3% vs 2.9% for controls). In addition, a majority of BrdU-containing hepatocytes were 4N following 5 and 10 days of WY and MCP [34.3% (WY) and 16.8% (MCP) vs 1.8% and 1.1% for controls, respectively, for 2 X 2N (5 days) as a percentage of total hepatocytes]. Hepatocytes with intermediary DNA content (between tetraploid and octaploid) from MCP- and WY-treated rats were predominantly mononuclear, the percentage of binucleate hepatocytes being similar to or less than the percentage of binucleate cells within the total tetraploid hepatocyte population. These data suggest that polyploidization is induced by PP and induction of S-phase by WY and MCP occurs primarily in 4N hepatocytes in mature F344 rats and not within 2 X 2N hepatocytes. Identification of a ploidy subpopulation at risk for tumor development in rodents is essential for clarifying the role of cell replication in risk assessment studies of PP.
WY-14,643(WY)和甲基氯苯那酯(MCP)是大鼠体内的过氧化物酶体增殖剂(PP)和肝癌致癌物。MCP可导致肝脏多倍体化,并优先诱导幼年Alpk:AP大鼠的双核四倍体肝细胞(2×2N)进行复制性DNA合成。为比较WY和MCP对肝细胞倍性及倍性特异性DNA合成的影响,给雄性F344大鼠喂食含WY(饮食中0.1%)的饲料或灌胃MCP(玉米油中25毫克/千克/天),持续2、5或10天。每个处理组(包括玉米油和饮食对照组)的4只大鼠在每个时间点安乐死并灌注肝脏。为识别正在进行DNA合成的细胞,所有动物在安乐死前通过连续输注接受溴脱氧尿苷(BrdU)2或5天。使用单参数或双参数流式细胞术测定肝细胞倍性和DNA合成。成年雄性F344大鼠各倍性子类占总肝细胞的百分比平均值±标准误为:2N = 3.4±0.7%,4N = 69.9±1.9%,2×2N = 14.4±2.4%,8N = 2.2±0.4%,2×4N = 9.6±0.9%。在任何时间点,WY或MCP均未引起2×2N或4N倍性子类比例的显著改变。然而,WY在2、5和10天时导致8N肝细胞增加(2天,5.2%对对照组的2.2%;5天,7.0%对对照组的3.1%;10天,6.4%对对照组的3.6%),MCP在5和10天时也有同样情况(5天,6.3%对对照组的2.5%;10天,5.3%对对照组的2.9%)。此外,在WY和MCP处理5天和10天后,大多数含BrdU的肝细胞为4N[2×2N(5天)占总肝细胞的百分比,WY组为34.3%,MCP组为16.8%,而对照组分别为1.8%和1.1%]。MCP和WY处理大鼠中具有中间DNA含量(四倍体和八倍体之间)的肝细胞主要为单核,双核肝细胞的百分比与总四倍体肝细胞群体中双核细胞的百分比相似或更低。这些数据表明,PP可诱导多倍体化,WY和MCP诱导的S期主要发生在成熟F344大鼠的4N肝细胞中,而非2×2N肝细胞中。识别啮齿动物中具有肿瘤发生风险的倍性子群体对于阐明细胞复制在PP风险评估研究中的作用至关重要。